IVF success rates are climbing, but here’s what’s really changed
In vitro fertilization (IVF) is a fertility treatment in which eggs are fertilized with sperm outside the body and an embryo is transferred to the uterus. IVF success rates have improved over time, but the change is not simply that each cycle now guarantees a baby: outcomes reflect better laboratory practice, embryo assessment, treatment choices, and the age and health of the people receiving care. U.S. data show that about 37% of IVF cycles using a patient’s own eggs resulted in a live birth per intended egg retrieval in 2022, while outcomes varied sharply by age. Understanding how clinics measure success, what has changed, and what still shapes the odds matters to patients weighing treatment, cost, and risk.
IVF success rates: what the numbers measure
The Centers for Disease Control and Prevention (CDC) describes assisted reproductive technology (ART) as fertility treatment in which eggs or embryos are handled outside the body; IVF is the most common type. A “success rate” is not one universal measure. It may mean pregnancy per embryo transfer, live birth per transfer, or live birth per intended egg retrieval. These denominators answer different questions, so a higher-looking percentage is not automatically evidence that a clinic or treatment is more effective.
Live birth is the outcome that matters most
A live birth rate counts treatment cycles that result in at least one live-born infant. The CDC’s 2022 National ART Summary reported that, among transfers using patients’ own eggs, live birth occurred in roughly 40% of transfers overall. A separate CDC measure—live birth per intended egg retrieval, which can include one or more transfers arising from that retrieval—was about 37% for patients using their own eggs. The figures differ because a transfer-based rate excludes retrievals that never produce an embryo transfer.
Age changes the interpretation
Age is one of the strongest predictors of IVF outcomes using a patient’s own eggs, largely because both the number of available eggs and the likelihood of chromosomal abnormalities change over time. CDC 2022 data put live birth per intended retrieval at approximately 46% for patients younger than 35, compared with about 7% for those aged 45 and older. These are population averages, not individualized forecasts; diagnosis, prior treatment, clinic practices, and other health factors also matter.
This distinction sets up the central question: if outcomes have improved, which parts of IVF have actually changed—and which apparent gains reflect measurement or patient differences?
IVF success rates and the changes behind improvement
There is no single intervention that explains rising IVF success. The American Society for Reproductive Medicine (ASRM) and the CDC describe outcomes as the product of patient characteristics, treatment choices, laboratory performance, and the way a cycle is counted. Improvements in embryo culture and freezing have helped clinics manage treatment more flexibly, while embryo testing can help select among embryos in some circumstances. These developments do not remove the effects of age or ensure success.
Embryo culture and laboratory practice
Embryo culture is the process of growing fertilized eggs in a controlled laboratory environment before transfer or freezing. Advances in culture systems, quality control, and laboratory monitoring have made it possible to observe embryos for longer and coordinate treatment more consistently. Such changes may improve selection and workflow, but an embryo’s appearance or development in the laboratory cannot perfectly predict whether it will implant or result in a healthy birth.
Vitrification and frozen embryo transfer
Vitrification is a rapid-freezing method that reduces ice-crystal formation and has made embryo freezing more dependable than earlier slow-freezing approaches. It allows embryos from one retrieval to be stored for later transfer and supports “freeze-all” treatment when a fresh transfer is not advisable. Frozen transfers can be useful for medical or scheduling reasons, but they are not automatically better for every patient; the appropriate approach depends on clinical circumstances.
Blastocyst transfer and embryo selection
A blastocyst is an embryo that has developed for about five or six days after fertilization. Growing embryos to this stage can help clinicians choose among embryos that continue developing, but some patients may have no embryo reach transfer, particularly when few eggs or embryos are available. The result is a trade-off: a higher success rate per transfer can coexist with fewer transfers, so patients should compare outcomes using the same denominator.
Preimplantation genetic testing
Preimplantation genetic testing for aneuploidy (PGT-A) examines sampled cells from an embryo to estimate whether it has the expected number of chromosomes. It may help guide embryo selection in selected cases, especially when multiple embryos are available, but it is not a guarantee of implantation or live birth. ASRM’s committee guidance emphasizes that routine PGT-A for every IVF patient has not been shown to improve the overall chance of having a baby for all groups. Testing also has limitations, including mosaic results, in which sampled cells show differing chromosome patterns.
Together, these technologies explain part of the progress, but they also show why “better IVF” does not mean the same thing for every patient. The next step is to examine how clinic reporting and treatment strategy can make success rates look different.
IVF success rates and how to compare clinics
Clinic success rates are statistics for groups of patients, not promises for an individual. The CDC publishes U.S. clinic-level ART data, while the Society for Assisted Reproductive Technology (SART) also reports outcomes from participating clinics. Both emphasize that patients should compare similar groups and outcomes rather than selecting a clinic solely because it displays the largest percentage.
Check the denominator and patient group
A clinic may report pregnancy per transfer, live birth per transfer, or cumulative live birth following a retrieval. The last measure can include multiple transfers using embryos from one retrieval and may better represent the full outcome of that treatment attempt, although definitions and follow-up periods matter. When reviewing a report, check whether it separates outcomes by age, own eggs versus donor eggs, and fresh versus frozen transfers.
Consider case mix and treatment choices
A clinic treating more patients with favorable prognoses may show higher success than one accepting a broader or more complex patient population. Conversely, transferring only embryos judged most likely to succeed can raise success per transfer while leaving out cycles that did not reach transfer. Ask how the clinic handles patients with your age, diagnosis, and treatment history, and whether the reported number is a clinic-wide average or a comparable subgroup.
Ask about safety as well as success
A healthy singleton birth is generally a more useful goal than maximizing pregnancy rates without regard to complications. The CDC and ASRM support limiting the number of embryos transferred when appropriate to reduce multiple pregnancy risks. Multiple gestation is associated with increased risks such as preterm birth and low birth weight. Patients can ask how a clinic balances the chance of success against the safety of the pregnant patient and babies.
IVF success rates: what has not changed
Technology has changed more rapidly than the basic biology of reproduction. IVF remains an uncertain process: not every egg fertilizes, not every embryo continues developing, and not every transferred embryo implants. A positive pregnancy test also does not always lead to a live birth. National averages help explain patterns, but they cannot determine an individual’s outcome.
Age and egg supply remain central
The CDC’s age-stratified results illustrate why timing and egg source matter. For patients using their own eggs, the chance of live birth declines substantially at older ages, even when treatment uses modern laboratory methods. Donor eggs can change the age-related pattern because outcomes are more closely associated with the donor’s age, but donor treatment has its own medical, financial, legal, and personal considerations.
Treatment burden, access, and cost still matter
IVF may involve injections, repeated monitoring, procedures, time away from work, and emotional strain. Insurance coverage and out-of-pocket costs vary widely, shaping who can access treatment and how many cycles they can pursue. A clinic’s reported success rate does not capture these burdens. Patients should discuss likely treatment steps, alternatives, medication costs, and the possibility that more than one retrieval may be needed.
Conclusion: IVF success rates are improving, but context is essential
IVF success rates reflect measurable progress in embryo culture, freezing, and treatment planning, alongside the way outcomes are counted and the patients included in a clinic’s statistics. The most meaningful comparisons focus on live birth, use the same denominator, account for age and egg source, and consider safety—not just pregnancy per transfer. Before beginning treatment, review CDC or SART clinic data and ask a fertility specialist for an estimate tailored to your diagnosis and circumstances. No statistic can guarantee an individual result, but clear questions can make the numbers more useful.
Sources: Centers for Disease Control and Prevention, 2022 Assisted Reproductive Technology Fertility Clinic and National Summary Report, https://www.cdc.gov/art/reports/2022/; Centers for Disease Control and Prevention, Assisted Reproductive Technology (ART), https://www.cdc.gov/art/; American Society for Reproductive Medicine, The use of preimplantation genetic testing for aneuploidy: a committee opinion, https://www.asrm.org/practice-guidance/practice-committee-documents/the-use-of-preimplantation-genetic-testing-for-aneuploidy-a-committee-opinion-2024/; American Society for Reproductive Medicine, Guidance on the limits to the number of embryos to transfer: a committee opinion, https://www.asrm.org/practice-guidance/practice-committee-documents/guidance-on-the-limits-to-the-number-of-embryos-to-transfer-a-committee-opinion-2021/; Society for Assisted Reproductive Technology, Patient Resources and Clinic Data, https://www.sart.org/patients/.